Vaccines — MCQs

Q: Which vaccine is contraindicated in a 3-monthold infant with recurrent respiratory illness?

DPT (Diphtheria, Pertussis, Tetanus). ***DPT (Diphtheria, Pertussis, Tetanus)*** - While DPT is routinely given in infancy, the **pertussis component** (particularly the whole-cell vaccine formulation) can exacerbate existing **respiratory conditions** or be problematic in infants with a history of **unstable neurological disorders**. - Recurrent respiratory illness in a 3-month-old may indicate underlying pulmonary compromise, for which the pertussis component's side effects (e.g., fever, fussiness) could be poorly tolerated or confound diagnosis. *Measles vaccine* - The measles vaccine (MMR) is typically administered at **12-15 months of age**, not at 3 months. - Measles vaccine is a **live attenuated vaccine**, but its contraindications are primarily related to severe immunosuppression or recent immunoglobulin receipt, not recurrent respiratory illness in this age group. *DT (Diphtheria and Tetanus)* - The DT vaccine (without the pertussis component) is generally considered **safe** for infants and often used if the pertussis component is *contraindicated*. - This option does not address the specific concern regarding the pertussis component in the context of recurrent respiratory illness. *Inactivated polio vaccine (IPV)* - IPV is an **inactivated vaccine**, meaning it contains killed virus, and thus carries a very low risk of vaccine-related adverse events. - Recurrent respiratory illness is **not a contraindication** for IPV, which is part of routine infant immunization schedules. *Hepatitis B vaccine* - Hepatitis B vaccine is an **inactivated vaccine** routinely given at birth and as part of the infant immunization schedule. - Recurrent respiratory illness is **not a contraindication** for Hepatitis B vaccine, which is safe and well-tolerated in infants.

Q: A child is a known case of HIV with a CD4 count of 50 . Which of the following vaccines should be avoided in this child?

BCG. ***BCG*** - **BCG vaccine** contains live attenuated bacteria and is **absolutely contraindicated** in severely immunocompromised individuals, such as an **HIV-positive child with a CD4 count of 50**, due to the risk of disseminated BCG infection. - A **CD4 count of 50** indicates severe immunosuppression (AIDS stage), making live vaccines like BCG extremely unsafe. - **This is the most strongly contraindicated vaccine** in this clinical scenario. *MMR* - **MMR (Measles, Mumps, Rubella) vaccine** is a live attenuated vaccine that is generally contraindicated in **severely immunocompromised HIV patients** with **CD4 count <200 cells/µL**. - With a **CD4 count of 50**, this vaccine would typically be contraindicated due to severe immunosuppression. - However, **BCG carries a higher risk** of disseminated infection and is more strongly contraindicated. *OPV* - **OPV (Oral Polio Vaccine)** is a live attenuated vaccine and is contraindicated in **immunocompromised individuals** including those with severe HIV infection. - However, most vaccination programs now use **IPV (Inactivated Polio Vaccine)** which is safe for HIV-positive children. - **BCG remains the most critical contraindication** in severe immunosuppression. *TT* - **TT (Tetanus Toxoid)** is an inactivated vaccine containing no live organisms and is **safe for immunocompromised individuals**, including those with HIV. - Inactivated vaccines are generally recommended for HIV-positive individuals to provide protection against common infections. *DPT* - **DPT (Diphtheria, Pertussis, Tetanus)** is an inactivated vaccine and is **safe for immunocompromised children** with HIV. - It does not pose a risk of infection from the vaccine itself and is crucial for protecting against these severe childhood diseases.

Q: A girl child has had recurrent yeast and respiratory viral infections since she was 3 months old. Considering studies for her immune status, which of the following vaccines is contraindicated?

Measles/MMR. ***Measles/MMR*** - This patient's history of **recurrent yeast and respiratory viral infections** suggests a potential **immunodeficiency**, which is a contraindication for **live attenuated vaccines** like MMR (Measles, Mumps, Rubella). - Administering live attenuated vaccines to immunocompromised individuals can lead to **uncontrolled replication of the vaccine virus**, causing severe disease. *Killed IPV (Inactivated Poliovirus Vaccine)* - **Inactivated vaccines** do not contain live viruses and are generally safe for immunocompromised individuals. - The patient's underlying immune status does not contraindicate killed vaccines, as there is **no risk of vaccine-induced infection**. *DPT (Diphtheria, Pertussis, Tetanus)* - DPT is a **non-live vaccine** (consisting of toxoids and inactivated bacterial components), making it safe for individuals with immunodeficiency. - These vaccines do not pose a risk of causing the disease in immunocompromised patients, even if their **immune response is suboptimal**. *TT/Td (Tetanus toxoid)* - Tetanus toxoid vaccines are **inactivated vaccines** and are therefore safe for individuals with impaired immune function. - The concern with immunodeficiency is the **ability to mount an effective immune response**, not the safety of the vaccine itself. *Hepatitis B vaccine* - Hepatitis B is a **recombinant inactivated vaccine** that is safe for immunocompromised patients. - While the vaccine may have **reduced immunogenicity** in this population, it is not contraindicated and does not pose a risk of vaccine-induced disease.

Q: A 6-year-old girl presents to the clinic for a general checkup before her last scheduled DTaP vaccination. Her mother is concerned about mild swelling and redness at the site of injection after her daughter’s previous DTaP administration. The patient has mild spastic cerebral palsy. She was diagnosed with epilepsy at the age of 5, and it is well-controlled with levetiracetam. She is allergic to penicillin. Currently, she complains of malaise and mild breathlessness. The mother noted that her daughter has been sluggish for the last 3 days. Her vital signs are as follows: the blood pressure is 100/60 mm Hg, the heart rate is 90/min, the respiratory rate is 22/min, and the temperature is 38.8°C (101.8°F). On physical examination, the patient has slightly enlarged submandibular lymph nodes bilaterally and oropharyngeal erythema. On auscultation, there are diminished vesicular breath sounds with a few respiratory crackles over the lower lobe of the left lung. Which of the following factors requires delaying the patient’s vaccination?

Signs of pneumonia. ***Signs of pneumonia*** - The patient's symptoms (malaise, breathlessness, fever, submandibular lymphadenopathy, oropharyngeal erythema, diminished breath sounds, and crackles) are indicative of an **acute, moderate-to-severe illness**, most likely pneumonia. - A definitive acute illness, such as suspected pneumonia, is a **precaution** for vaccine administration, warranting a delay until symptoms resolve to avoid attributing worsening symptoms to the vaccine or compounding the illness. - Per **CDC/ACIP guidelines**, moderate-to-severe acute illness (with or without fever) is a precaution for all vaccines. *Cerebral palsy* - **Cerebral palsy** is a chronic, stable neurological condition and is generally **not a contraindication or precaution** for routine vaccinations, including DTaP. - Patients with cerebral palsy should receive recommended vaccines to prevent infectious diseases, as they may be at increased risk for complications from these infections. *Mild swelling and redness at the site of injection after the previous vaccine administration* - **Mild local reactions** (redness, swelling, tenderness) at the injection site are common and **expected side effects** of many vaccines, including DTaP. - Such mild reactions are **not considered a contraindication or precaution** for subsequent doses. *Penicillin allergy* - An allergy to penicillin is generally **not relevant** to vaccine administration, as vaccines do not contain penicillin or related antibiotics. - The DTaP vaccine does not contain components that would cross-react with a penicillin allergy. *Epilepsy* - **Well-controlled epilepsy**, especially when managed with medication like levetiracetam, is **not a contraindication or precaution** for vaccination. - Most vaccines are safe for individuals with epilepsy, and the benefit of preventing infectious diseases outweighs any theoretical risk.

Q: A 2-year-old boy presents for a routine checkup. The patient’s mother says that he has been ‘under the weather’ for the past few days. She did not measure his temperature at home but states that he has felt warm. She denies any episodes of diarrhea or vomiting. No significant past medical history or current medications. The patient attends daycare. He is due for a hepatitis A vaccine. The patient was born at term with no prenatal or perinatal complications. The vital signs include: temperature 37.8°C (100.1°F), blood pressure 112/62 mm Hg, pulse 80/min, respiratory rate 18/min, and oxygen saturation 99% on room air. The patient is alert and responsive. The physical exam is unremarkable. Which of the following is the most appropriate next step in the management of this patient?

Administer the hepatitis A vaccine. ***Administer the hepatitis A vaccine*** - The patient has a **low-grade fever** (37.8°C), which is generally **not considered a contraindication** for vaccination, especially if the child is otherwise well and active. - The patient's presentation of being "under the weather" with an unremarkable physical exam and stable vitals suggests a **mild illness**, allowing for routine vaccinations to proceed. *Order a complete blood count* - A **CBC is not indicated** at this time, as the patient displays only mild, non-specific symptoms and has a normal physical exam. - This would be reserved for cases with more concerning signs of infection or systemic illness, such as persistent high fever, lethargy, or specific clinical findings. *Order liver function tests* - **Liver function tests are not warranted** as the patient has no symptoms or signs suggestive of liver disease (e.g., jaundice, right upper quadrant pain, dark urine). - While the patient is due for a hepatitis A vaccine, there is no clinical evidence of active hepatitis or liver dysfunction requiring diagnostic workup. *Strep rapid antigen detection test* - The patient has **no symptoms consistent with streptococcal pharyngitis**, such as sore throat, tonsillar exudates, or cervical lymphadenopathy. - Given the lack of specific symptoms, testing for strep throat would be inappropriate and potentially lead to unnecessary antibiotic use. *Delay the hepatitis A immunization until next visit* - Delaying vaccination is only recommended for **moderate to severe acute illnesses** with or without fever, or for certain contraindications. - A mild illness with low-grade fever, as in this case, is generally **not a reason to postpone** routine immunizations, as per CDC guidelines.

A previously healthy 11-year-old boy is brought to the emergency department because of a 3-day history of fever, cough, and a runny nose. During this period, he has also had pink, itchy eyes. The patient emigrated from Syria 2 weeks ago. His parents died 6 months ago. He has not yet received any routine childhood vaccinations. He lives at a foster home with ten other refugees; two have similar symptoms. He appears anxious and is sweating. His temperature is 39.2°C (102.5°F), pulse is 100/min, respirations are 20/min, and blood pressure is 125/75 mm Hg. Examination shows conjunctivitis of both eyes. There are multiple bluish-gray lesions on an erythematous background on the buccal mucosa and the soft palate. This patient is at increased risk for which of the following complications?

A 13-month-old girl is brought to the physician because of a pruritic rash for 2 days. The girl's mother says she noticed a few isolated skin lesions on her trunk two days ago that appear to be itching. The girl received her routine immunizations 18 days ago. Her mother has been giving her ibuprofen for her symptoms. The patient has no known sick contacts. She is at the 71st percentile for height and the 64th percentile for weight. She is in no acute distress. Her temperature is 38.1°C (100.6°F), pulse is 120/min, and respirations are 26/min. Examination shows a few maculopapular and pustular lesions distributed over the face and trunk. There are some excoriation marks and crusted lesions as well. Which of the following is the most likely explanation for these findings?

A 4-year-old girl is brought to her pediatrician for a routine check-up. She was diagnosed with sickle cell disease last year after an episode of dactylitis. She was started on hydroxyurea, with no painful crises or acute chest episodes since starting the medication. Which of the following is an appropriate preventive measure for this patient?

A 6-year-old girl presents to the clinic for a general checkup before her last scheduled DTaP vaccination. Her mother is concerned about mild swelling and redness at the site of injection after her daughter’s previous DTaP administration. The patient has mild spastic cerebral palsy. She was diagnosed with epilepsy at the age of 5, and it is well-controlled with levetiracetam. She is allergic to penicillin. Currently, she complains of malaise and mild breathlessness. The mother noted that her daughter has been sluggish for the last 3 days. Her vital signs are as follows: the blood pressure is 100/60 mm Hg, the heart rate is 90/min, the respiratory rate is 22/min, and the temperature is 38.8°C (101.8°F). On physical examination, the patient has slightly enlarged submandibular lymph nodes bilaterally and oropharyngeal erythema. On auscultation, there are diminished vesicular breath sounds with a few respiratory crackles over the lower lobe of the left lung. Which of the following factors requires delaying the patient’s vaccination?

A 2-year-old boy presents for a routine checkup. The patient’s mother says that he has been ‘under the weather’ for the past few days. She did not measure his temperature at home but states that he has felt warm. She denies any episodes of diarrhea or vomiting. No significant past medical history or current medications. The patient attends daycare. He is due for a hepatitis A vaccine. The patient was born at term with no prenatal or perinatal complications. The vital signs include: temperature 37.8°C (100.1°F), blood pressure 112/62 mm Hg, pulse 80/min, respiratory rate 18/min, and oxygen saturation 99% on room air. The patient is alert and responsive. The physical exam is unremarkable. Which of the following is the most appropriate next step in the management of this patient?

Q10

An 11-year-old boy is brought to his pediatrician by his parents for the routine Tdap immunization booster dose that is given during adolescence. Upon reviewing the patient’s medical records, the pediatrician notes that he was immunized according to CDC recommendations, with the exception that he received a catch-up Tdap immunization at the age of 8 years. When the pediatrician asks the boy’s parents about this delay, they inform the doctor that they immigrated to this country 3 years ago from Southeast Asia, where the child had not been immunized against diphtheria, tetanus, and pertussis. Therefore, he received a catch-up series at 8 years of age, which included the first dose of the Tdap vaccine. Which of the following options should the pediatrician choose to continue the boy’s immunization schedule?

Vaccines US Medical PG Practice Questions and MCQs

Question 1: An unimmunized 5 -year-old child presents to the OPD with a white membranous layer on inspection, suggesting diphtheria. What is the appropriate prophylaxis for a 2 -year-old contact who has completed their vaccination?

A. No prophylaxis needed
B. Toxoid
C. Immunoglobulins
D. Penicillin (Correct Answer)
E. Erythromycin

Explanation: ***Penicillin*** - For a **fully vaccinated contact** of a diphtheria case, **antibiotic prophylaxis** (e.g., penicillin or erythromycin) is recommended to prevent carriage and transmission of *Corynebacterium diphtheriae*. - This approach aims to eradicate the organism from the respiratory tract, even if the contact is otherwise protected from the disease itself. - **Penicillin** is a commonly used first-line agent for this purpose. *Erythromycin* - **Erythromycin** is also an acceptable antibiotic for diphtheria prophylaxis and is particularly useful in penicillin-allergic patients. - Both penicillin and erythromycin are effective for preventing carriage; the choice between them may depend on local guidelines, patient allergies, and availability. - In this context, either would be clinically appropriate, but penicillin is often listed as the primary option in standard guidelines. *No prophylaxis needed* - This is incorrect because even vaccinated individuals can become **asymptomatic carriers** of *C. diphtheriae* and transmit the infection to unimmunized or under-immunized contacts. - Prophylaxis is crucial for **breaking the chain of transmission** in a household or close contact setting. *Toxoid* - **Diphtheria toxoid** is the active component of the diphtheria vaccine, which stimulates the immune system to produce antibodies against diphtheria toxin, preventing the disease. - While important for ongoing immunity, administering the toxoid as an immediate prophylaxis for a fully vaccinated contact is not the primary intervention for preventing carriage; **antibiotics are used for this purpose**. *Immunoglobulins* - **Diphtheria antitoxin** (DAT), which contains immunoglobulins, is used for the **treatment of active diphtheria disease** by neutralizing the circulating toxin. - It is not indicated for prophylaxis in vaccinated contacts, as their immune system is already primed to handle potential exposure to the toxin, and the goal of prophylaxis here is to prevent colonization rather than toxin effects.

Question 2: Which vaccine is contraindicated in a 3-monthold infant with recurrent respiratory illness?

A. DT (Diphtheria and Tetanus)
B. Measles vaccine
C. DPT (Diphtheria, Pertussis, Tetanus) (Correct Answer)
D. Inactivated polio vaccine (IPV)
E. Hepatitis B vaccine

Explanation: ***DPT (Diphtheria, Pertussis, Tetanus)*** - While DPT is routinely given in infancy, the **pertussis component** (particularly the whole-cell vaccine formulation) can exacerbate existing **respiratory conditions** or be problematic in infants with a history of **unstable neurological disorders**. - Recurrent respiratory illness in a 3-month-old may indicate underlying pulmonary compromise, for which the pertussis component's side effects (e.g., fever, fussiness) could be poorly tolerated or confound diagnosis. *Measles vaccine* - The measles vaccine (MMR) is typically administered at **12-15 months of age**, not at 3 months. - Measles vaccine is a **live attenuated vaccine**, but its contraindications are primarily related to severe immunosuppression or recent immunoglobulin receipt, not recurrent respiratory illness in this age group. *DT (Diphtheria and Tetanus)* - The DT vaccine (without the pertussis component) is generally considered **safe** for infants and often used if the pertussis component is *contraindicated*. - This option does not address the specific concern regarding the pertussis component in the context of recurrent respiratory illness. *Inactivated polio vaccine (IPV)* - IPV is an **inactivated vaccine**, meaning it contains killed virus, and thus carries a very low risk of vaccine-related adverse events. - Recurrent respiratory illness is **not a contraindication** for IPV, which is part of routine infant immunization schedules. *Hepatitis B vaccine* - Hepatitis B vaccine is an **inactivated vaccine** routinely given at birth and as part of the infant immunization schedule. - Recurrent respiratory illness is **not a contraindication** for Hepatitis B vaccine, which is safe and well-tolerated in infants.

Question 3: A child is a known case of HIV with a CD4 count of 50 . Which of the following vaccines should be avoided in this child?

A. MMR
B. TT
C. BCG (Correct Answer)
D. DPT
E. OPV

Explanation: ***BCG*** - **BCG vaccine** contains live attenuated bacteria and is **absolutely contraindicated** in severely immunocompromised individuals, such as an **HIV-positive child with a CD4 count of 50**, due to the risk of disseminated BCG infection. - A **CD4 count of 50** indicates severe immunosuppression (AIDS stage), making live vaccines like BCG extremely unsafe. - **This is the most strongly contraindicated vaccine** in this clinical scenario. *MMR* - **MMR (Measles, Mumps, Rubella) vaccine** is a live attenuated vaccine that is generally contraindicated in **severely immunocompromised HIV patients** with **CD4 count <200 cells/µL**. - With a **CD4 count of 50**, this vaccine would typically be contraindicated due to severe immunosuppression. - However, **BCG carries a higher risk** of disseminated infection and is more strongly contraindicated. *OPV* - **OPV (Oral Polio Vaccine)** is a live attenuated vaccine and is contraindicated in **immunocompromised individuals** including those with severe HIV infection. - However, most vaccination programs now use **IPV (Inactivated Polio Vaccine)** which is safe for HIV-positive children. - **BCG remains the most critical contraindication** in severe immunosuppression. *TT* - **TT (Tetanus Toxoid)** is an inactivated vaccine containing no live organisms and is **safe for immunocompromised individuals**, including those with HIV. - Inactivated vaccines are generally recommended for HIV-positive individuals to provide protection against common infections. *DPT* - **DPT (Diphtheria, Pertussis, Tetanus)** is an inactivated vaccine and is **safe for immunocompromised children** with HIV. - It does not pose a risk of infection from the vaccine itself and is crucial for protecting against these severe childhood diseases.

Question 4: A girl child has had recurrent yeast and respiratory viral infections since she was 3 months old. Considering studies for her immune status, which of the following vaccines is contraindicated?

A. Killed IPV (Inactivated Poliovirus Vaccine)
B. DPT (Diphtheria, Pertussis, Tetanus)
C. TT/Td (Tetanus toxoid)
D. Measles/MMR (Correct Answer)
E. Hepatitis B vaccine

Explanation: ***Measles/MMR*** - This patient's history of **recurrent yeast and respiratory viral infections** suggests a potential **immunodeficiency**, which is a contraindication for **live attenuated vaccines** like MMR (Measles, Mumps, Rubella). - Administering live attenuated vaccines to immunocompromised individuals can lead to **uncontrolled replication of the vaccine virus**, causing severe disease. *Killed IPV (Inactivated Poliovirus Vaccine)* - **Inactivated vaccines** do not contain live viruses and are generally safe for immunocompromised individuals. - The patient's underlying immune status does not contraindicate killed vaccines, as there is **no risk of vaccine-induced infection**. *DPT (Diphtheria, Pertussis, Tetanus)* - DPT is a **non-live vaccine** (consisting of toxoids and inactivated bacterial components), making it safe for individuals with immunodeficiency. - These vaccines do not pose a risk of causing the disease in immunocompromised patients, even if their **immune response is suboptimal**. *TT/Td (Tetanus toxoid)* - Tetanus toxoid vaccines are **inactivated vaccines** and are therefore safe for individuals with impaired immune function. - The concern with immunodeficiency is the **ability to mount an effective immune response**, not the safety of the vaccine itself. *Hepatitis B vaccine* - Hepatitis B is a **recombinant inactivated vaccine** that is safe for immunocompromised patients. - While the vaccine may have **reduced immunogenicity** in this population, it is not contraindicated and does not pose a risk of vaccine-induced disease.

Question 5: A previously healthy 11-year-old boy is brought to the emergency department because of a 3-day history of fever, cough, and a runny nose. During this period, he has also had pink, itchy eyes. The patient emigrated from Syria 2 weeks ago. His parents died 6 months ago. He has not yet received any routine childhood vaccinations. He lives at a foster home with ten other refugees; two have similar symptoms. He appears anxious and is sweating. His temperature is 39.2°C (102.5°F), pulse is 100/min, respirations are 20/min, and blood pressure is 125/75 mm Hg. Examination shows conjunctivitis of both eyes. There are multiple bluish-gray lesions on an erythematous background on the buccal mucosa and the soft palate. This patient is at increased risk for which of the following complications?

A. Coronary artery aneurysm
B. Subacute sclerosing panencephalitis (Correct Answer)
C. Immune thrombocytopenic purpura
D. Non-Hodgkin lymphoma
E. Aplastic crisis

Explanation: ***Subacute sclerosing panencephalitis*** - This patient presents with classic symptoms of **measles** (rubeola): fever, cough, runny nose (coryza), conjunctivitis, and especially the pathognomonic **Koplik spots** (bluish-gray lesions on an erythematous background on buccal mucosa). His unvaccinated status, recent immigration from a region with potentially lower vaccination rates, and exposure to other symptomatic individuals further support this diagnosis. - **Subacute sclerosing panencephalitis (SSPE)** is a rare, devastating, and fatal complication of measles, caused by persistent measles virus infection in the brain. It typically develops years after the initial measles infection. *Coronary artery aneurysm* - **Coronary artery aneurysms** are a classic complication of **Kawasaki disease**, which is characterized by fever, conjunctivitis, oral mucosal changes (strawberry tongue, cracked lips), rash, and cervical lymphadenopathy. - While there is conjunctivitis, the presence of **Koplik spots** and the typical "cough, coryza, conjunctivitis" prodrome are highly indicative of measles, not Kawasaki disease. *Immune thrombocytopenic purpura* - **Immune thrombocytopenic purpura (ITP)** is a disorder causing isolated low platelet count due to autoimmune destruction of platelets, leading to easy bruising and bleeding. It can be triggered by viral infections, but it is not a direct or specific complication of measles itself. - The patient's symptoms are primarily respiratory and mucocutaneous, with no indication of bleeding or bruising associated with thrombocytopenia. *Non-Hodgkin lymphoma* - **Non-Hodgkin lymphoma** is a type of cancer that originates in lymphocytes, a type of white blood cell. While some viral infections (e.g., Epstein-Barr virus, HIV) are associated with an increased risk of specific lymphomas, measles itself is not directly linked to a significant increased risk of non-Hodgkin lymphoma. - The current clinical picture points to an acute viral infection and its potential long-term neurological sequelae, not a malignancy. *Aplastic crisis* - An **aplastic crisis** is a sudden, severe reduction in red blood cell production, most commonly triggered by **Parvovirus B19 infection** in individuals with underlying chronic hemolytic anemias (e.g., sickle cell disease, hereditary spherocytosis). - The patient's symptoms are characteristic of measles, not parvovirus, and there is no information to suggest an underlying hemolytic anemia.

Question 6: A 13-month-old girl is brought to the physician because of a pruritic rash for 2 days. The girl's mother says she noticed a few isolated skin lesions on her trunk two days ago that appear to be itching. The girl received her routine immunizations 18 days ago. Her mother has been giving her ibuprofen for her symptoms. The patient has no known sick contacts. She is at the 71st percentile for height and the 64th percentile for weight. She is in no acute distress. Her temperature is 38.1°C (100.6°F), pulse is 120/min, and respirations are 26/min. Examination shows a few maculopapular and pustular lesions distributed over the face and trunk. There are some excoriation marks and crusted lesions as well. Which of the following is the most likely explanation for these findings?

A. Antigen contact with presensitized T-lymphocytes
B. Reactivation of virus dormant in dorsal root ganglion
C. Immune complex formation and deposition
D. Crosslinking of preformed IgE antibodies
E. Replication of the attenuated vaccine strain (Correct Answer)

Explanation: ***Replication of the attenuated vaccine strain*** - The presentation of a **pruritic rash with maculopapular and pustular lesions**, along with crusted lesions, describes the classic **polymorphic rash** of **varicella (chickenpox)**. - The timing of the rash, appearing **18 days after routine immunizations** (which commonly include the attenuated **MMRV vaccine** at 12-15 months), strongly suggests a vaccine-induced varicella rash due to the replication of the live attenuated virus. *Antigen contact with presensitized T-lymphocytes* - This mechanism describes a **Type IV hypersensitivity reaction** (delayed-type hypersensitivity), such as **contact dermatitis** or a **tuberculin skin test**. - While it can cause a rash, it typically presents differently (e.g., vesicles in contact dermatitis) and the timeline of 18 days post-vaccination is less consistent with a primary contact-mediated reaction causing widespread varicella-like lesions. *Reactivation of virus dormant in dorsal root ganglion* - This process describes the pathogenesis of **herpes zoster (shingles)**, which occurs due to the reactivation of the **latent varicella-zoster virus (VZV)** from the dorsal root ganglia. - Shingles typically presents with a **dermatomal rash** in older individuals or immunocompromised patients, not a widespread polymorphic rash in an otherwise healthy toddler. *Immune complex formation and deposition* - This mechanism describes a **Type III hypersensitivity reaction**, where antigen-antibody complexes deposit in tissues, leading to inflammation. - Conditions like **serum sickness**, **lupus**, or some forms of **vasculitis** are examples, which present with fever, arthralgia, and urticarial or purpuric rashes, differing from the described varicella-like lesions. *Crosslinking of preformed IgE antibodies* - This mechanism describes a **Type I hypersensitivity reaction**, commonly known as an **allergic reaction**. - It typically results in **urticaria (hives)**, angioedema, or anaphylaxis, which are acute reactions characterized by wheals and pruritus, rather than the polymorphic rash with pustules and crusts seen here.

Question 7: A 4-year-old girl is brought to her pediatrician for a routine check-up. She was diagnosed with sickle cell disease last year after an episode of dactylitis. She was started on hydroxyurea, with no painful crises or acute chest episodes since starting the medication. Which of the following is an appropriate preventive measure for this patient?

A. Splenectomy
B. Intranasal influenza vaccine
C. Human papillomavirus vaccine
D. Pneumococcal vaccine (Correct Answer)
E. Parenteral penicillin G

Explanation: ***Pneumococcal vaccine*** - Children with **sickle cell disease** are at high risk of severe **pneumococcal infections** due to functional asplenia, making vaccination crucial. - The **pneumococcal conjugate vaccine (PCV13)** and **pneumococcal polysaccharide vaccine (PPSV23)** are recommended to protect against *Streptococcus pneumoniae*. *Splenectomy* - Although **functional asplenia** is common in sickle cell disease, prophylactic splenectomy is *not* a routine recommendation due to the associated risks and the availability of other preventive measures. - **Splenectomy** is generally reserved for specific indications such as refractory **splenic sequestration crises** or hypersplenism. *Intranasal influenza vaccine* - The **intranasal live attenuated influenza vaccine (LAIV)** is **contraindicated** in children with sickle cell disease because of concerns about the live virus potentially exacerbating disease complications. - The **inactivated influenza vaccine (IIV)**, given intramuscularly, is recommended annually for these patients. *Human papillomavirus vaccine* - The **HPV vaccine** is important for preventing cervical cancer and other HPV-related conditions, but it is typically indicated for adolescents starting at age 11 or 12, not a 4-year-old. - It is not a primary or immediate preventive measure for the acute complications associated with **sickle cell disease** in early childhood. *Parenteral penicillin G* - While **oral penicillin prophylaxis** (penicillin V) is indeed recommended for children with sickle cell disease from infancy until at least age 5 to prevent pneumococcal sepsis, this question asks about **parenteral** penicillin G. - **Parenteral penicillin G** (given by injection) is reserved for treating active infections or specific situations where oral administration is not feasible, not for routine daily prophylaxis in a stable outpatient. - The standard prophylaxis is **oral penicillin V**, taken twice daily at home.

Question 8: A 6-year-old girl presents to the clinic for a general checkup before her last scheduled DTaP vaccination. Her mother is concerned about mild swelling and redness at the site of injection after her daughter’s previous DTaP administration. The patient has mild spastic cerebral palsy. She was diagnosed with epilepsy at the age of 5, and it is well-controlled with levetiracetam. She is allergic to penicillin. Currently, she complains of malaise and mild breathlessness. The mother noted that her daughter has been sluggish for the last 3 days. Her vital signs are as follows: the blood pressure is 100/60 mm Hg, the heart rate is 90/min, the respiratory rate is 22/min, and the temperature is 38.8°C (101.8°F). On physical examination, the patient has slightly enlarged submandibular lymph nodes bilaterally and oropharyngeal erythema. On auscultation, there are diminished vesicular breath sounds with a few respiratory crackles over the lower lobe of the left lung. Which of the following factors requires delaying the patient’s vaccination?

A. Cerebral palsy
B. Mild swelling and redness at the site of injection after the previous vaccine administration
C. Signs of pneumonia (Correct Answer)
D. Penicillin allergy
E. Epilepsy

Explanation: ***Signs of pneumonia*** - The patient's symptoms (malaise, breathlessness, fever, submandibular lymphadenopathy, oropharyngeal erythema, diminished breath sounds, and crackles) are indicative of an **acute, moderate-to-severe illness**, most likely pneumonia. - A definitive acute illness, such as suspected pneumonia, is a **precaution** for vaccine administration, warranting a delay until symptoms resolve to avoid attributing worsening symptoms to the vaccine or compounding the illness. - Per **CDC/ACIP guidelines**, moderate-to-severe acute illness (with or without fever) is a precaution for all vaccines. *Cerebral palsy* - **Cerebral palsy** is a chronic, stable neurological condition and is generally **not a contraindication or precaution** for routine vaccinations, including DTaP. - Patients with cerebral palsy should receive recommended vaccines to prevent infectious diseases, as they may be at increased risk for complications from these infections. *Mild swelling and redness at the site of injection after the previous vaccine administration* - **Mild local reactions** (redness, swelling, tenderness) at the injection site are common and **expected side effects** of many vaccines, including DTaP. - Such mild reactions are **not considered a contraindication or precaution** for subsequent doses. *Penicillin allergy* - An allergy to penicillin is generally **not relevant** to vaccine administration, as vaccines do not contain penicillin or related antibiotics. - The DTaP vaccine does not contain components that would cross-react with a penicillin allergy. *Epilepsy* - **Well-controlled epilepsy**, especially when managed with medication like levetiracetam, is **not a contraindication or precaution** for vaccination. - Most vaccines are safe for individuals with epilepsy, and the benefit of preventing infectious diseases outweighs any theoretical risk.

Question 9: A 2-year-old boy presents for a routine checkup. The patient’s mother says that he has been ‘under the weather’ for the past few days. She did not measure his temperature at home but states that he has felt warm. She denies any episodes of diarrhea or vomiting. No significant past medical history or current medications. The patient attends daycare. He is due for a hepatitis A vaccine. The patient was born at term with no prenatal or perinatal complications. The vital signs include: temperature 37.8°C (100.1°F), blood pressure 112/62 mm Hg, pulse 80/min, respiratory rate 18/min, and oxygen saturation 99% on room air. The patient is alert and responsive. The physical exam is unremarkable. Which of the following is the most appropriate next step in the management of this patient?

A. Order a complete blood count
B. Order liver function tests
C. Strep rapid antigen detection test
D. Administer the hepatitis A vaccine (Correct Answer)
E. Delay the hepatitis A immunization until next visit

Explanation: ***Administer the hepatitis A vaccine*** - The patient has a **low-grade fever** (37.8°C), which is generally **not considered a contraindication** for vaccination, especially if the child is otherwise well and active. - The patient's presentation of being "under the weather" with an unremarkable physical exam and stable vitals suggests a **mild illness**, allowing for routine vaccinations to proceed. *Order a complete blood count* - A **CBC is not indicated** at this time, as the patient displays only mild, non-specific symptoms and has a normal physical exam. - This would be reserved for cases with more concerning signs of infection or systemic illness, such as persistent high fever, lethargy, or specific clinical findings. *Order liver function tests* - **Liver function tests are not warranted** as the patient has no symptoms or signs suggestive of liver disease (e.g., jaundice, right upper quadrant pain, dark urine). - While the patient is due for a hepatitis A vaccine, there is no clinical evidence of active hepatitis or liver dysfunction requiring diagnostic workup. *Strep rapid antigen detection test* - The patient has **no symptoms consistent with streptococcal pharyngitis**, such as sore throat, tonsillar exudates, or cervical lymphadenopathy. - Given the lack of specific symptoms, testing for strep throat would be inappropriate and potentially lead to unnecessary antibiotic use. *Delay the hepatitis A immunization until next visit* - Delaying vaccination is only recommended for **moderate to severe acute illnesses** with or without fever, or for certain contraindications. - A mild illness with low-grade fever, as in this case, is generally **not a reason to postpone** routine immunizations, as per CDC guidelines.

Question 10: An 11-year-old boy is brought to his pediatrician by his parents for the routine Tdap immunization booster dose that is given during adolescence. Upon reviewing the patient’s medical records, the pediatrician notes that he was immunized according to CDC recommendations, with the exception that he received a catch-up Tdap immunization at the age of 8 years. When the pediatrician asks the boy’s parents about this delay, they inform the doctor that they immigrated to this country 3 years ago from Southeast Asia, where the child had not been immunized against diphtheria, tetanus, and pertussis. Therefore, he received a catch-up series at 8 years of age, which included the first dose of the Tdap vaccine. Which of the following options should the pediatrician choose to continue the boy’s immunization schedule?

A. A single dose of Td vaccine at 18 years of age
B. A single dose of Td vaccine now
C. No further vaccination needed
D. A single dose of Tdap vaccine now
E. A single dose of Tdap vaccine at 13 years of age (Correct Answer)

Explanation: ***A single dose of Tdap vaccine at 13 years of age*** - The CDC recommends a **minimum interval of 5 years** between Tdap doses when Tdap is given as part of a catch-up series. - Since this patient received his first Tdap at age 8, the earliest he should receive the adolescent booster is at **age 13** (5 years later). - This timing ensures adequate spacing while still providing the recommended adolescent booster for **pertussis, tetanus, and diphtheria** protection. - The 5-year interval prevents excessive antigen exposure and optimizes immune response. *A single dose of Tdap vaccine now* - Giving Tdap now would result in only a **3-year interval** from the previous Tdap dose at age 8. - This violates the CDC recommendation of a **minimum 5-year interval** between Tdap doses. - Shorter intervals may increase local reactogenicity without improving protection. *A single dose of Td vaccine now* - While this would provide tetanus and diphtheria protection, it would **not protect against pertussis**, which is a critical component of adolescent vaccination. - The Tdap vaccine is specifically recommended for adolescents to boost waning pertussis immunity. - Additionally, giving it now would still be earlier than the recommended 5-year interval from the previous pertussis-containing vaccine. *A single dose of Td vaccine at 18 years of age* - This option would result in a **10-year gap** from the last pertussis-containing vaccine, leaving the adolescent vulnerable during high-risk years. - The adolescent Tdap booster is specifically timed for ages 11-13 to protect during peak transmission periods in middle and high school. - Waiting until 18 would miss the critical window for pertussis protection. *No further vaccination needed* - While the patient completed a catch-up series, the CDC still recommends an **adolescent Tdap booster** even for those who received Tdap in a catch-up series. - The adolescent booster is important to maintain immunity against pertussis, which wanes significantly over time. - The booster should be given at age 13 to maintain the 5-year minimum interval.

Question 11: A mother brings her 4-year-old boy to the physician, as the boy has a 7-day history of foul-smelling diarrhea, abdominal cramps, and fever. The mother adds that he has been vomiting as well, and she is very much worried. The child is in daycare, and the mother endorses sick contacts with both family and friends. The boy has not been vaccinated as the parents do not think it is necessary. On physical exam, the child appears dehydrated. Stool examination is negative for blood cells, pus, and ova or parasites. What is the most likely diagnosis?

A. Rotavirus infection (Correct Answer)
B. Cryptosporidiosis
C. Irritable bowel syndrome
D. C. difficile colitis
E. Norovirus infection

Explanation: ***Rotavirus infection*** - The classic presentation of **foul-smelling diarrhea**, vomiting, abdominal cramps, and fever in an **unvaccinated child** attending daycare strongly suggests rotavirus. This virus is a common cause of **severe gastroenteritis** in young children. - The absence of bacterial or parasitic indicators in the stool (blood cells, pus, ova/parasites) further narrows the diagnosis to a **viral cause**, with rotavirus being highly prevalent in this age group, especially without vaccination. *Cryptosporidiosis* - While it causes **watery diarrhea** and abdominal cramps, it is typically associated with **contaminated water sources** and often produces **oocysts** detectable in stool, which were not found in this case. - The symptoms in the child are more classic for a common viral gastroenteritis rather than a parasitic infection, especially given the **absence of parasitic elements** on examination. *Irritable bowel syndrome* - **IBS** is a chronic functional gastrointestinal disorder and rarely presents acutely with fever and vomiting in a 4-year-old. - Its diagnosis involves specific **Rome IV criteria** related to chronic abdominal pain and changes in bowel habits, which are not met by the acute presentation here. *C. difficile colitis* - **C. difficile colitis** typically follows **antibiotic use** or is acquired in healthcare settings and commonly causes **bloody diarrhea** and significant abdominal pain. - The diarrhea is usually more profuse and the stool may contain **leukocytes** or be positive for C. difficile toxin, neither of which is indicated in the patient's presentation. *Norovirus infection* - Norovirus causes acute gastroenteritis with **vomiting** and **diarrhea**, but the diarrhea is often less foul-smelling and of shorter duration than described. - While possible, the classic triad of **foul-smelling diarrhea, vomiting, and fever** in an unvaccinated child with sick contacts more strongly points to rotavirus, which tends to cause more severe and prolonged symptoms in young, unvaccinated children.

Question 12: A 12-year-old girl presents to her primary care physician for a well-child visit. She has a history of asthma and uses her inhaler 1-2 times per week when she exercises. She does not smoke and is not currently sexually active; however, she does have a boyfriend. She lives with her mother in an apartment and is doing well in school. Her temperature is 97.6°F (36.4°C), blood pressure is 124/75 mmHg, pulse is 80/min, respirations are 12/min, and oxygen saturation is 98% on room air. Physical exam is notable for a healthy young girl with no findings. Which of the following is most appropriate for this patient at this time?

A. Pelvic examination
B. Serum lipids and cholesterol
C. HPV vaccine (Correct Answer)
D. Hypertension screening
E. Human papilloma virus PCR

Explanation: ***HPV vaccine*** - The **HPV vaccine** is recommended for all adolescents, typically starting at **age 11 or 12**, to prevent HPV-related cancers and genital warts. - While she may not be currently sexually active, the vaccine is most effective when administered **before exposure** to the virus. *Pelvic examination* - A **pelvic examination** is not routinely recommended for a 12-year-old girl during a well-child visit unless there are specific symptoms or concerns. - The patient has no complaints indicating the need for such an invasive procedure. *Serum lipids and cholesterol* - **Lipid screening** is typically recommended for adolescents with risk factors like a family history of early cardiovascular disease or dyslipidemia, or for all adolescents sometime between ages 9 and 11 and again between 17 and 21. - This patient does not present with any specific risk factors that would warrant immediate screening at this age, and it is not the most appropriate *initial* intervention. *Hypertension screening* - **Blood pressure** is already routinely measured at well-child visits, as indicated by the patient's vitals (124/75 mmHg). This is part of the standard physical exam, not a separate intervention to be chosen. - While her blood pressure is at the higher end for her age, further evaluation would come after initial screening, which has already occurred. *Human papilloma virus PCR* - **HPV PCR testing** is used for screening for cervical cancer in adults (typically women age 25 and older) or for diagnostic evaluation of HPV-related lesions. - This test is not indicated for routine screening in a 12-year-old girl, as it does not prevent HPV and is not a part of adolescent preventive care.

Question 13: An 8-year-old boy is brought to the physician because of worsening confusion and lethargy for the last hour. He has had high-grade fever, productive cough, fatigue, and malaise for 2 days. He was diagnosed with sickle cell anemia at the age of 2 years but has not seen a physician in over a year. His temperature is 38.9°C (102°F), pulse is 133/min, respirations are 33/min, and blood pressure is 86/48 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 92%. The patient does not respond to verbal commands. Examination shows conjunctival pallor and scleral icterus. Inspiratory crackles are heard at the left lung base. Laboratory studies show: Hemoglobin 8.1 g/dL Leukocyte count 17,000/mm3 Platelet count 200,000/mm3 Which of the following is most likely to have prevented this patient's condition?

A. Chronic transfusion therapy
B. Pneumococcal vaccination (Correct Answer)
C. Folic acid
D. Low molecular weight heparin
E. Hydroxyurea

Explanation: ***Pneumococcal vaccination*** - This patient with **sickle cell anemia** is presenting with symptoms suggestive of severe **bacterial sepsis and pneumonia** (fever, altered mental status, hypotension, hypoxemia, leukocytosis, crackles). Patients with sickle cell disease are at high risk for **encapsulated bacterial infections**, particularly with *Streptococcus pneumoniae*, due to **functional asplenia** (autosplenectomy from recurrent infarctions). - **Pneumococcal vaccines** (both **PCV13 conjugate vaccine** and **PPSV23 polysaccharide vaccine**) are crucial for preventing such severe infections in this population. Children with sickle cell disease should receive PCV13 in infancy followed by PPSV23 at age 2 years, with boosters as recommended. - The neglect of medical care for over a year, including missed vaccinations, likely contributed to this life-threatening presentation. *Chronic transfusion therapy* - While chronic transfusion therapy can reduce **stroke risk** and prevent recurrent **vaso-occlusive crises**, it is not primarily used to prevent infectious complications like the one described. - Transfusions do not directly improve immune function against encapsulated bacteria. *Folic acid* - **Folic acid supplementation** is essential in sickle cell anemia to support increased erythropoiesis due to chronic hemolysis. - It helps prevent **megaloblastic anemia** but does not prevent bacterial infections. *Low molecular weight heparin* - **Low molecular weight heparin** is an anticoagulant used to prevent or treat **venous thromboembolism**. - It has no role in preventing bacterial infections associated with functional asplenia in sickle cell disease. *Hydroxyurea* - **Hydroxyurea** increases **fetal hemoglobin (HbF)**, which reduces sickling, vaso-occlusive crises, and acute chest syndrome. - While it improves overall health and can indirectly reduce infection risk by decreasing hospitalization and improving splenic function in some patients, it does not directly confer protection against encapsulated bacterial infections like vaccination does.

Question 14: A 4-year-old boy is brought to the emergency department with difficulty breathing. His mother reports that he developed a fever last night and began to have trouble breathing this morning. The boy was born at 39 weeks gestation via spontaneous vaginal delivery. He is unvaccinated (conscientious objection by the family) and is meeting all developmental milestones. At the hospital, his vitals are temperature 39.8°C (103.6°F), pulse 122/min, respiration rate 33/min, blood pressure 110/66 mm Hg, and SpO2 93% on room air. On physical examination, he appears ill with his neck hyperextended and chin protruding. His voice is muffled and is drooling. The pediatrician explains that there is one particular bacteria that commonly causes these symptoms. At what age should the patient have first received vaccination to prevent this condition from this particular bacteria?

A. At birth
B. At 2-months-old (Correct Answer)
C. Between 9- and 12-months-old
D. At 6-months-old
E. Between 12- and 15-months-old

Explanation: ***At 2-months-old*** - The clinical presentation with **high fever**, **difficulty breathing**, **neck hyperextension**, **muffled voice**, and **drooling** in an unvaccinated child strongly suggests **epiglottitis**, likely caused by *Haemophilus influenzae type b* (Hib). - The **Hib vaccine** is routinely given starting at **2 months of age** as part of the multi-dose primary series to protect against this life-threatening condition. *At birth* - While some vaccines like **Hepatitis B** are given at birth, the Hib vaccine is not typically administered at this age. - Vaccinating at birth would not align with the standard immunization schedule for *Haemophilus influenzae type b*. *Between 9- and 12-months-old* - This age range typically corresponds to the **measles, mumps, and rubella (MMR)** and **varicella** vaccines, or a booster dose of other vaccines, not the initial primary series for Hib. - Delaying the first Hib vaccination until this age would leave infants vulnerable during a critical period. *At 6-months-old* - By 6 months, a child should have already received at least **two doses** of the Hib vaccine if following the recommended schedule. - Administering the first dose at 6 months would significantly delay protection against invasive Hib disease. *Between 12- and 15-months-old* - This age range is typically when the **final booster dose** of the Hib vaccine is given, not the initial vaccination. - The primary series for Hib should have been completed much earlier to provide timely protection.

Question 15: A 15-month-old girl is brought to her primary care physician for a follow-up visit to receive the 4th dose of her DTaP vaccine. She is up-to-date on her vaccinations. She received her 1st dose of MMR, 1st dose of varicella, 3rd dose of HiB, 4th dose of PCV13, and 3rd dose of polio vaccine 3 months ago. Thirteen days after receiving these vaccinations, the child developed a fever up to 40.5°C (104.9°F) and had one generalized seizure that lasted for 2 minutes. She was taken to the emergency department. The girl was sent home after workup for the seizure was unremarkable and her temperature subsided with acetaminophen therapy. She has not had any other symptoms since then. She has no history of serious illness and takes no medications. Her mother is concerned about receiving further vaccinations because she is afraid of the girl having more seizures. Her vital signs are within normal limits. Examination shows no abnormalities. Which of the following is the most appropriate recommendation at this time?

A. Administration of the DTaP vaccine as scheduled (Correct Answer)
B. Administration of the DTaP vaccine with valproic acid
C. Administration of a reduced-dose DTaP vaccine
D. Refrain from administration of the DTaP vaccine
E. Administration of the DTaP vaccine with prophylactic aspirin

Explanation: ***Administration of the DTaP vaccine as scheduled*** - The seizure experienced by the child was a **febrile seizure**, triggered by a fever following vaccination, and not a contraindication to future DTaP doses. - The timing of the seizure (**13 days post-vaccination**) suggests it was most likely related to the **MMR vaccine**, which commonly causes delayed fever (5-12 days) and febrile seizures, rather than the pertussis component or other vaccines given simultaneously. - Since the child did **not receive DTaP** at the visit when the febrile seizure occurred, there is no evidence that pertussis-containing vaccines trigger seizures in this patient. - The **unremarkable workup** and the child's return to normal health indicate the seizure was benign and not indicative of an underlying seizure disorder or severe adverse reaction. - **Simple febrile seizures are not a contraindication** to DTaP vaccination per CDC/ACIP guidelines. *Administration of the DTaP vaccine with valproic acid* - **Valproic acid** is an anti-epileptic drug and is not indicated for the prevention of simple febrile seizures following vaccination. - Prophylactic use of anti-epileptic drugs for vaccination-related febrile seizures is generally not recommended due to potential side effects and lack of clear benefit. *Administration of a reduced-dose DTaP vaccine* - There is **no such thing as a reduced-dose DTaP vaccine** for standard administration in children of this age. - Reducing the vaccine dose would compromise its efficacy and protective immunity. *Refrain from administration of the DTaP vaccine* - **Febrile seizures are not a contraindication** to receiving further DTaP vaccination. - Withholding the vaccine would leave the child unprotected against **diphtheria, tetanus, and pertussis**, which are serious and potentially life-threatening diseases. *Administration of the DTaP vaccine with prophylactic aspirin* - **Aspirin is contraindicated in children** due to the risk of **Reye's syndrome**, especially during viral illnesses or when fever is present. - It should not be used as a prophylactic measure for vaccination-related fever or seizures.

Question 16: A 28-year-old woman comes to the emergency department for a 1-week history of jaundice and nausea. She recalls eating some seafood last weekend at a cookout. She lives at home with her 2-year-old son who attends a daycare center. The child's immunizations are up-to-date, and his last hepatitis A vaccine was administered 6 weeks ago. The woman's temperature is 37.5°C (99.5°F), pulse is 82/min, and blood pressure is 134/84 mm Hg. Examination shows scleral icterus. The liver is palpated 2-cm below the right costal margin and is tender. Her serum studies show: Total bilirubin 3.4 mg/dL Alkaline phosphatase 89 U/L AST 185 U/L ALT 723 U/L Hepatitis A IgM antibody positive Hepatitis B surface antibody positive Hepatitis B surface antigen negative Hepatitis B core IgM antibody negative Hepatitis C antibody negative Which of the following health maintenance recommendations is most appropriate for the child at this time?

A. Isolate the child
B. Administer hepatitis B immunoglobulin and hepatitis B vaccine
C. No additional steps are needed (Correct Answer)
D. Administer hepatitis B immunoglobulin only
E. Administer hepatitis A vaccine and hepatitis A immunoglobulin

Explanation: ***No additional steps are needed*** - The child received his **last hepatitis A vaccine 6 weeks ago**, which provides adequate protection against hepatitis A infection. - According to **CDC/ACIP guidelines**, children who have received **at least one dose** of hepatitis A vaccine do **not require post-exposure prophylaxis** (neither additional vaccine nor immunoglobulin) after exposure to hepatitis A. - One dose of hepatitis A vaccine provides protection within **2-4 weeks**, and since 6 weeks have elapsed, the child is already immune. - The child's **immunizations are up-to-date**, confirming he is on the appropriate hepatitis A vaccination schedule (2-dose series). *Administer hepatitis A vaccine and hepatitis A immunoglobulin* - This would be appropriate for **previously unvaccinated** individuals exposed to hepatitis A, immunocompromised patients, or infants under 12 months. - However, this child has **already been vaccinated** 6 weeks ago and therefore has adequate protection. - Administering both vaccine and immunoglobulin is **unnecessary** and not indicated per current guidelines when prior vaccination has occurred. *Isolate the child* - Isolation is not the primary recommendation for hepatitis A post-exposure management in household contacts. - The focus should be on **prevention through immunization**, but this child is already protected by prior vaccination. - Standard hygiene measures (handwashing) are recommended but formal isolation is not necessary. *Administer hepatitis B immunoglobulin and hepatitis B vaccine* - The mother's serology shows **HBsAg negative** and **HBsAb positive**, indicating she is **immune to hepatitis B** (likely from prior vaccination) and not currently infected. - There is **no risk of hepatitis B transmission** from the mother to the child. - This intervention addresses the wrong infection entirely. *Administer hepatitis B immunoglobulin only* - This is inappropriate because the mother does **not have active hepatitis B infection** (HBsAg negative). - This option does not address the **hepatitis A exposure**, which is the relevant concern in this scenario. - Hepatitis B immunoglobulin is indicated only for exposure to hepatitis B, not hepatitis A.

Question 17: An 1800-g (4.0-lb) male newborn is delivered to a 26-year-old woman, gravida 2, para 1, at 33 weeks' gestation. The Apgar scores are 7 at 1 minute and 8 at 5 minutes. The pregnancy was complicated by iron deficiency anemia. The mother has no other history of serious illness. She has smoked one-half pack of cigarettes daily for the past 10 years. She does not drink alcohol. She has never used illicit drugs. Pregnancy and delivery of her first child were complicated by placenta previa. The mother has received all appropriate immunizations. It is most appropriate for the physician to recommend which of the following to the mother regarding her son's immunizations?

A. Give first dose of varicella vaccine at 2 months of chronological age
B. Give first dose of influenza vaccine at 2 months of chronological age
C. Give first dose of diphtheria and tetanus toxoids, acellular pertussis (DTaP) vaccine at 2 months of chronological age (Correct Answer)
D. Give first dose of hepatitis B vaccine at 3 months of chronological age
E. Give first dose of Haemophilus influenzae type b vaccine at 3 months of chronological age

Explanation: ***Give first dose of diphtheria and tetanus toxoids, acellular pertussis (DTaP) vaccine at 2 months of chronological age*** - The **DTaP vaccine** is routinely recommended for infants starting at **2 months of chronological age**, regardless of prematurity, as long as they are **clinically stable**. - This timing is crucial for providing early protection against these serious diseases due to the infant's developing immune system and potential vulnerability. *Give first dose of varicella vaccine at 2 months of chronological age* - The **varicella vaccine** is a **live attenuated vaccine** and is typically recommended at **12 to 15 months of age**, not at 2 months. - Administering it to a young infant, especially a premature one, is not standard practice and could be less effective or pose risks. *Give first dose of influenza vaccine at 2 months of chronological age* - The **influenza vaccine** is not recommended for infants younger than **6 months of age**. - Infants receive passive immunity from the mother or rely on cocooning strategies for protection in their first 6 months. *Give first dose of Haemophilus influenza type b vaccine at 3 months of chronological age* - The first dose of the **Hib vaccine** is typically given at **2 months of chronological age**, not 3 months, aligning with other routine infant immunizations. - Delaying this vaccine could leave the infant vulnerable for an unnecessary period. *Give first dose of hepatitis B vaccine at 3 months of chronological age* - For premature infants, the **hepatitis B vaccine** is typically initiated at **birth** (if weighing >2000g) or at **1 month of age** or discharge, provided the mother is HBsAg negative. - Delaying until 3 months is not consistent with current recommendations, especially with the risk factors present (premature birth).

Question 18: A 2-month-old girl is brought to the physician by her father for a routine well-child examination. She is given a vaccine that contains polyribosylribitol phosphate conjugated to a toxoid carrier. The vaccine is most likely to provide immunity against which of the following pathogens?

A. Haemophilus influenzae (Correct Answer)
B. Neisseria meningitidis
C. Bordetella pertussis
D. Streptococcus pneumoniae
E. Corynebacterium diphtheriae

Explanation: **Haemophilus influenzae** - The vaccine described, containing **polyribosylribitol phosphate (PRP)** conjugated to a toxoid carrier, is characteristic of the **Haemophilus influenzae type b (Hib) vaccine**. - PRP is the **polysaccharide capsule** of *H. influenzae* type b, and conjugating it to a protein (toxoid carrier) allows for T-cell dependent immunity, effective in infants. *Neisseria meningitidis* - While *N. meningitidis* also has a **polysaccharide capsule** and vaccines are available, their capsular components differ (e.g., serogroups A, C, Y, W-135, or B outer membrane protein). - The description of **polyribosylribitol phosphate** is specific to *H. influenzae* type b. *Bordetella pertussis* - Vaccines against *Bordetella pertussis* are typically **acellular pertussis vaccines (aP)**, which contain purified components like pertussis toxoid, filamentous hemagglutinin, and pertactin, not a PRP conjugate. - These vaccines target bacterial toxins and adhesins, not a polysaccharide capsule unique to PRP. *Streptococcus pneumoniae* - Vaccines for *S. pneumoniae* (pneumococcal vaccines) use **capsular polysaccharides** from various serotypes, often conjugated to a protein carrier (e.g., diphtheria toxoid), but the specific polysaccharide is not PRP. - The structure and serotypes of pneumococcal capsular polysaccharides are distinct from PRP. *Corynebacterium diphtheriae* - The vaccine for *C. diphtheriae* is the **diphtheria toxoid**, which is an inactivated form of the diphtheria toxin, not a polysaccharide conjugate. - It provides immunity by inducing antibodies against the toxin, preventing its harmful effects.

Question 19: A 12-month-old boy presents for a routine checkup. The patient immigrated from the Philippines with his parents a few months ago. No prior immunization records are available. The patient’s mother claims that he had a series of shots at 6 months of age which gave him a severe allergic reaction with swelling of the tongue and the face. She also remembers that he had the same reaction when she introduced solid foods to his diet, including carrots, eggs, and bananas. Which of the following vaccinations are not recommended for this patient?

A. Measles, mumps, and rubella (MMR) vaccine
B. Hepatitis B vaccine
C. Varicella vaccine
D. Intranasal influenza vaccine
E. Intramuscular influenza vaccine (Correct Answer)

Explanation: ***Important Note on Current Guidelines*** Based on **current CDC/ACIP guidelines (2023-2024)**, egg allergy alone is **no longer a contraindication** to influenza vaccines. However, this question tests knowledge of vaccine safety in the context of **severe anaphylaxis to a prior vaccination**. ***Intramuscular influenza vaccine*** - **Historically**, this was considered the most concerning option for patients with severe egg allergy, as many influenza vaccines were produced using egg-based culture methods - **Current practice**: Per CDC guidelines, persons with egg allergy of any severity can receive any age-appropriate influenza vaccine, as egg protein content is minimal or absent in modern formulations - However, if this patient had a **documented anaphylactic reaction to the influenza vaccine itself** (not just eggs), then it would be contraindicated - Given the timing (6 months) and symptoms described, this represents the **historically correct answer**, though modern practice has evolved *Measles, mumps, and rubella (MMR) vaccine* - MMR vaccine is grown in **chick embryo fibroblast cells**, NOT in eggs, and contains **no egg protein** - **Safe for patients with egg allergy** - no contraindication based on egg allergy - Should be administered on schedule for catch-up immunization *Hepatitis B vaccine* - Produced using **recombinant DNA technology in yeast cells** - Contains **no egg protein** and no animal-derived proteins - **No contraindication** for this patient - safe to administer *Varicella vaccine* - Grown in **human diploid cell cultures**, NOT in eggs - Contains **no egg protein** - **Safe for patients with egg allergy** - no contraindication - Should be administered as part of catch-up immunization *Intranasal influenza vaccine (LAIV)* - Like the intramuscular formulation, **current guidelines allow administration** to patients with egg allergy of any severity - Contains similar or less egg protein than inactivated vaccines in modern formulations - **Not contraindicated** based solely on egg allergy per current CDC guidelines

Question 20: A 4-month-old boy is brought to the physician by his parents for a well-child examination. He has cystic fibrosis diagnosed by newborn screening. His parents report frequent feedings and large-volume and greasy stools. His 4-year-old brother has autism. Current medications include bronchodilators, pancreatic enzyme supplements, and fat-soluble vitamins. He is at the 18th percentile for height and 15th percentile for weight. Scattered wheezes are heard throughout both lung fields. Examination shows a distended and tympanic abdomen with no tenderness or guarding. Which of the following is a contraindication for administering one or more routine vaccinations?

A. Allergy to egg protein
B. History of cystic fibrosis
C. History of febrile seizures
D. Fever of 38.2°C (100.7°F) following previous vaccinations
E. History of intussusception (Correct Answer)

Explanation: ***History of intussusception*** - A history of **intussusception** is a **contraindication for rotavirus vaccine** administration, as the vaccine itself has a small risk of intussusception, particularly with the first dose. - The rotavirus vaccine is part of routine childhood immunizations, so this would be a contraindication for one of the routine vaccines. *Allergy to egg protein* - Egg allergy is a contraindication primarily for yellow fever vaccine and some influenza vaccines, which are typically not routine vaccinations for a 4-month-old. Many flu vaccines are egg-free or can be safely administered to those with egg allergy under supervision. - The MMR vaccine is generally safe for those with egg allergy since the amount of egg protein is negligible. *History of cystic fibrosis* - **Cystic fibrosis** itself is **not a contraindication** to routine vaccinations; in fact, patients with chronic conditions like CF are often *more* encouraged to receive vaccinations to prevent severe infections. - The patient's symptoms (poor growth, greasy stools, wheezing) are manifestations of CF, not reasons to defer vaccination. *History of febrile seizures* - A history of **febrile seizures** is generally **not a contraindication** to routine vaccinations. - Parents should be counseled on fever management after vaccination, but the risk of recurrent febrile seizures is not increased by vaccination to a level that warrants deferral. *Fever of 38.2°C (100.7°F) following previous vaccinations* - A **low-grade fever** after vaccination is a common and **expected immune response**, not a contraindication for future doses. - Only a **severe allergic reaction** (e.g., anaphylaxis) to a previous dose of a vaccine or one of its components is a contraindication to subsequent doses of that specific vaccine.

Question 21: A 12-month-old girl is brought to her pediatrician for a checkup and vaccines. The patient’s mother wants to send her to daycare but is worried about exposure to unvaccinated children and other potential sources of infection. The toddler was born at 39 weeks gestation via spontaneous vaginal delivery. She is up to date on all vaccines. She does not walk yet but stands in place and can say a few words. The toddler drinks formula and eats a mixture of soft vegetables and pureed meals. She has no current medications. On physical exam, the vital signs include: temperature 37.0°C (98.6°F), blood pressure 95/50 mm Hg, pulse 130/min, and respiratory rate 28/min. The patient is alert and responsive. The remainder of the exam is unremarkable. Which of the following is most appropriate for this patient at this visit?

A. Meningococcal vaccine
B. Gross motor workup and evaluation
C. Rotavirus vaccine
D. Referral for speech pathology
E. MMR vaccine (Correct Answer)

Explanation: ***MMR vaccine*** - The **measles, mumps, and rubella (MMR) vaccine** is recommended for administration at **12-15 months of age**. - This timing offers protection against these common childhood diseases, which is especially important for children attending **daycare**. *Meningococcal vaccine* - The routine **meningococcal vaccine (MenACWY)** is typically recommended for adolescents at **11-12 years of age**, with a booster at 16 years. - While there are specific circumstances for earlier vaccination (e.g., high-risk conditions), it is **not routine** for a 12-month-old. *Gross motor workup and evaluation* - The patient's motor development, standing in place but not yet walking, is **within the normal range** for a 12-month-old. - A definitive **gross motor workup** would generally be considered if there were more significant delays or regressions. *Rotavirus vaccine* - The **rotavirus vaccine** series is typically given at **2, 4, and 6 months of age**, with the final dose administered no later than **8 months of age**. - A 12-month-old is **outside the recommended age range** for initiating or completing this vaccine series. *Referral for speech pathology* - Saying "a few words" at 12 months is **within the normal developmental milestone** for expressive language at this age. - A referral for **speech pathology** would generally be indicated for more significant language delays.

Question 22: A 3-year-old boy is brought to the emergency room by his mother with fever and difficulty breathing after receiving the BCG vaccine. He has never had a reaction to a vaccine before. He has a history of 2 salmonella infections over the past 2 years. He was born at 35 weeks’ gestation and spent one day in the neonatal intensive care unit. His parents' family histories are unremarkable. His temperature is 101°F (38.3°C), blood pressure is 80/55 mmHg, pulse is 135/min, and respirations are 24/min. On examination, he appears acutely ill. He has increased work of breathing with intercostal retractions. A petechial rash is noted on his trunk and extremities. A serological analysis in this patient would most likely reveal decreased levels of which of the following cytokines?

A. Interferon gamma (Correct Answer)
B. Tumor necrosis factor alpha
C. Interferon alpha
D. Interleukin 12
E. Interleukin 1

Explanation: ***Interferon gamma*** - The patient's history of **recurrent Salmonella infections**, severe reaction to **BCG vaccine** (causing disseminated disease), **fever**, **difficulty breathing**, and **petechial rash** are classic for **Mendelian Susceptibility to Mycobacterial Disease (MSMD)**, a primary immunodeficiency affecting the **IL-12/IFN-γ pathway**. - **Interferon-gamma (IFN-γ)** is the critical effector cytokine that activates macrophages to kill **intracellular pathogens** like **Salmonella** and **Mycobacteria**. Serological analysis would most likely show **decreased IFN-γ levels** because this cytokine is reduced in most forms of MSMD, whether the primary defect is in IL-12 production, IL-12 receptor signaling, or IFN-γ receptor function (where compensatory production doesn't overcome the functional deficit). - IFN-γ deficiency explains both the **recurrent Salmonella infections** and **disseminated BCG infection** seen in this patient. *Interleukin 12* - **IL-12** is produced by phagocytes (macrophages and dendritic cells) and stimulates **T cells and NK cells** to produce **IFN-γ**. Deficiency in IL-12 or its receptor (IL-12Rβ1 deficiency is the most common form of MSMD) would indeed cause decreased IFN-γ production. - While IL-12 levels could be decreased in **IL-12 production defects**, this is less commonly the primary finding on serological testing compared to IFN-γ. In the more common **IL-12 receptor deficiency**, IL-12 levels may be normal but signaling is impaired, leading to **decreased IFN-γ as the measurable downstream effect**. - **IFN-γ** is the more consistently decreased cytokine across different MSMD variants, making it the "most likely" finding. *Tumor necrosis factor alpha* - **TNF-α** is a proinflammatory cytokine involved in systemic inflammation, fever, and apoptosis. While it contributes to immunity against intracellular pathogens, primary TNF-α deficiency is not associated with the specific pattern of **recurrent Salmonella infections** and **severe BCG reactions** seen here. - The clinical picture points to a defect in the **IFN-γ-mediated macrophage activation pathway**, not TNF-α. *Interferon alpha* - **IFN-α** is primarily an antiviral cytokine crucial for innate immune responses against viral infections. - Deficiency in IFN-α typically manifests as severe or recurrent **viral infections**, not the **bacterial/mycobacterial susceptibility** pattern seen in this patient. *Interleukin 1* - **IL-1** is a proinflammatory cytokine involved in **fever** and acute phase responses. - Primary IL-1 deficiency causes impaired inflammatory responses and autoinflammatory syndromes (e.g., IL-1 receptor antagonist deficiency causes systemic inflammation), not the specific susceptibility to **intracellular bacterial infections** characteristic of IFN-γ pathway defects.

Question 23: A 1-year-old immigrant girl presents to her pediatrician for a routine well-child check. She has not received any recommended vaccines since birth. She attends daycare and remains healthy despite her daily association with several other children for the past 3 months at a home daycare facility. Which of the following phenomena explains why she has not contracted any vaccine-preventable diseases such as measles, diphtheria, or pertussis?

A. Genetic shift
B. Tolerance
C. Herd immunity (Correct Answer)
D. Immune evasion
E. Genetic drift

Explanation: ***Herd immunity*** - Herd immunity occurs when a significant portion of the population is immune to a contagious disease due to vaccination or prior infection, providing indirect protection to unimmunized individuals. - In a daycare setting where other children are likely vaccinated, the presence of immunized individuals reduces the likelihood of transmission to the unimmunized girl. - This is a classic example of **indirect protection** conferred by high vaccination rates in the community. *Genetic shift* - Genetic shift refers to an abrupt, major change in the influenza A virus, leading to new hemagglutinin and/or neuraminidase proteins, resulting in a novel subtype. - This phenomenon explains the emergence of new pandemic influenza strains, not the protection of an unimmunized child from common vaccine-preventable diseases. *Tolerance* - Tolerance in immunology is the failure to mount an immune response to an antigen, often referring to self-antigens. - It does not explain protection from external pathogens in an unvaccinated individual but rather the absence of an immune response to specific antigens. *Immune evasion* - Immune evasion is a strategy used by pathogens to avoid detection and elimination by the host's immune system. - This concept describes how pathogens survive and cause disease despite an immune response, not why an unimmunized host remains healthy. *Genetic drift* - Genetic drift involves small, gradual changes in genes over time, particularly in viruses, leading to antigenic variations. - While it explains the need for updated vaccines (e.g., annual influenza vaccines), it does not account for the protection of an unvaccinated individual from infection by common vaccine-preventable diseases.

Question 24: A 7-year-old African-American boy presents to his physician with fatigue, bone and abdominal pain, and mild jaundice. The pain is dull and remitting, and the patient complains it sometimes migrates from one extremity to another. His mother reports that his jaundice and pain have occurred periodically for the past 5 years. At the time of presentation, his vital signs are as follows: the blood pressure is 80/50 mm Hg, the heart rate is 87/min, the respiratory rate is 17/min, and the temperature is 36.5°C (97.7°F). On physical examination, the patient appears to be pale with mildly icteric sclera and mucous membranes. On auscultation, there is a soft systolic ejection murmur, and palpation reveals hepatosplenomegaly. His musculoskeletal examination shows no abnormalities. Laboratory investigations show the following results: Complete blood count Erythrocytes 3.7 x 106/mm3 Hgb 11 g/dL Total leukocyte count Neutrophils Lymphocytes Eosinophils Monocytes Basophils 7,300/mm3 51% 40% 2% 7% 0 Platelet count 151,000/mm3 Chemistry Total bilirubin 3.1 mg/dL (53 µmol/L) Direct bilirubin 0.5 mg/dL (8.55 µmol/L) A peripheral blood smear shows numerous sickle-shaped red blood cells. Among other questions, the patient’s mother asks you how his condition would influence his vaccination schedule. Which of the following statements is true regarding vaccination in this patient?

A. The patient’s condition does not affect his chances to get any infection; thus, additional vaccinations are not advised.
B. The patient should not receive meningococcal, pneumococcal, or Haemophilus influenzae vaccines, because they are likely to cause complications or elicit disease in his case.
C. The patient should receive the pneumococcal polysaccharide vaccine as soon as possible, because he is at higher risk of getting pneumococcal infection than other children.
D. The patient should receive serogroup B meningococcal vaccination at the age of 10 years. (Correct Answer)
E. The patient should receive serogroup B meningococcal vaccination as soon as possible, because he is at higher risk of getting meningococcal infection than other children.

Explanation: ***The patient should receive serogroup B meningococcal vaccination at the age of 10 years.*** - Patients with **sickle cell disease** (SCD) have **functional asplenia**, increasing their risk for invasive meningococcal disease from encapsulated bacteria. - The **MenACWY vaccine** should be given starting at age 2 months for high-risk children with asplenia, with boosters every 5 years. - The **MenB vaccine series** is recommended specifically for individuals **10 years and older** with anatomic or functional asplenia, including SCD patients. - This statement correctly identifies the age-appropriate timing for MenB vaccination according to **ACIP guidelines**. *The patient should receive serogroup B meningococcal vaccination as soon as possible, because he is at higher risk of getting meningococcal infection than other children.* - While SCD patients are at increased risk for meningococcal infections, the **MenB vaccine is not recommended before age 10 years**, even in high-risk patients. - At age 7, this patient should receive **MenACWY** if not already vaccinated, but MenB vaccination should wait until age 10. - The timing "as soon as possible" is incorrect for MenB vaccine in this 7-year-old patient. *The patient's condition does not affect his chances to get any infection; thus, additional vaccinations are not advised.* - This is completely false. **Sickle cell disease causes functional asplenia**, which dramatically increases the risk of overwhelming sepsis from encapsulated organisms (*S. pneumoniae*, *N. meningitidis*, *H. influenzae* type b). - Additional vaccinations beyond the routine schedule are **essential and life-saving** for SCD patients. *The patient should not receive meningococcal, pneumococcal, or Haemophilus influenzae vaccines, because they are likely to cause complications or elicit disease in his case.* - This is dangerously incorrect. These vaccines are **specifically recommended and safe** for patients with SCD. - Patients with functional asplenia are at **highest risk** for invasive disease from these encapsulated bacteria, making vaccination crucial. - These vaccines do not cause complications or elicit disease in SCD patients; they are inactivated or subunit vaccines. *The patient should receive the pneumococcal polysaccharide vaccine as soon as possible, because he is at higher risk of getting pneumococcal infection than other children.* - While SCD patients are at high risk for pneumococcal infection, the vaccination schedule is specific: **PCV13** in infancy, followed by **PPSV23** at age 2 years and older. - At age 7, if not previously vaccinated, catch-up vaccination is needed, but "as soon as possible" without specifying the proper sequence (PCV13 first, then PPSV23) and "polysaccharide vaccine" alone is imprecise. - The correct answer focuses on MenB at age 10, which is the most specific guideline-based recommendation among the options.

Practice by Chapter

Childhood immunization schedule

Practice Questions

Catch-up vaccination protocols

Practice Questions

Vaccine contraindications and precautions

Practice Questions

Live vs inactivated vaccines

Practice Questions

Vaccine adverse events

Practice Questions

Immunocompromised host vaccination

Practice Questions

Special population considerations

Practice Questions

Vaccine storage and handling

Practice Questions

Vaccine hesitancy approaches

Practice Questions

Global vaccination programs

Practice Questions

Travel vaccines for children

Practice Questions

New and emerging vaccines

Practice Questions

Vaccination documentation

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Vaccines — MCQs

Vaccines — MCQs

On this page

Practice by Chapter

Want unlimited practice?